ORLANDO — Combining lenalidomide with obinutuzumab in relapsed indolent lymphoma produced high overall response even in refractory patients and those who failed multiple lines of treatment, according to a presenter at the ASH Annual Meeting and Exposition.“The combination of lenalidomide and obinutuzumab is very active with high response rates in low-grade relapsed lymphoma and
SAN FRANCISCO — Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, according to an abstract…
SAN FRANCISCO — Among adults with interstitial lung disease requiring ICU care, women faced a lower adjusted likelihood for mortality vs. men, according to research…
ORLANDO — In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower risk for fractures than those who…
FORT LAUDERDALE, Fla. — Aflibercept 8 mg demonstrated sustained functional and anatomic improvements in patients with wet age-related macular degeneration through 156 weeks, according to…
WASHINGTON — At the Arthroscopy Association of North America Annual Meeting, researchers from Duke University discussed an augmented reality simulation curriculum they developed to teach…
Consuming high-quality carbohydrates and dietary fiber in midlife was tied to a 6% to 37% greater likelihood of healthy aging in women, according to a…
Annual universal depression screening for adolescents during primary care visits is cost effective, especially for certain patient populations, such as girls, a study in JAMA…
Participating in moderate to vigorous physical activity after a cancer diagnosis appeared to improve survival for patients with specific cancer types, according to research published…
President Donald J. Trump’s administration has announced major federal cuts in the name of efficiency, but this has massive repercussions for academic medical researchers and…
Recent findings regarding interferon and Janus kinase inhibition may hold clues to improving outcomes in patients with complex myositis, according to a presenter at the…
